623 related articles for article (PubMed ID: 9618505)
1. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma.
Herman JG; Umar A; Polyak K; Graff JR; Ahuja N; Issa JP; Markowitz S; Willson JK; Hamilton SR; Kinzler KW; Kane MF; Kolodner RD; Vogelstein B; Kunkel TA; Baylin SB
Proc Natl Acad Sci U S A; 1998 Jun; 95(12):6870-5. PubMed ID: 9618505
[TBL] [Abstract][Full Text] [Related]
2. Biallelic inactivation of hMLH1 by epigenetic gene silencing, a novel mechanism causing human MSI cancers.
Veigl ML; Kasturi L; Olechnowicz J; Ma AH; Lutterbaugh JD; Periyasamy S; Li GM; Drummond J; Modrich PL; Sedwick WD; Markowitz SD
Proc Natl Acad Sci U S A; 1998 Jul; 95(15):8698-702. PubMed ID: 9671741
[TBL] [Abstract][Full Text] [Related]
3. Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability.
Cunningham JM; Christensen ER; Tester DJ; Kim CY; Roche PC; Burgart LJ; Thibodeau SN
Cancer Res; 1998 Aug; 58(15):3455-60. PubMed ID: 9699680
[TBL] [Abstract][Full Text] [Related]
4. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.
Boland CR; Thibodeau SN; Hamilton SR; Sidransky D; Eshleman JR; Burt RW; Meltzer SJ; Rodriguez-Bigas MA; Fodde R; Ranzani GN; Srivastava S
Cancer Res; 1998 Nov; 58(22):5248-57. PubMed ID: 9823339
[TBL] [Abstract][Full Text] [Related]
5. Cancer epigenetics comes of age.
Jones PA; Laird PW
Nat Genet; 1999 Feb; 21(2):163-7. PubMed ID: 9988266
[TBL] [Abstract][Full Text] [Related]
6. MLH1 promoter hypermethylation is associated with the microsatellite instability phenotype in sporadic endometrial carcinomas.
Esteller M; Levine R; Baylin SB; Ellenson LH; Herman JG
Oncogene; 1998 Nov; 17(18):2413-7. PubMed ID: 9811473
[TBL] [Abstract][Full Text] [Related]
7. Unravelling epigenetic mechanisms in Cerastoderma edule genome: a comparison of healthy and neoplastic cockles.
Viña-Feás A; Temes-Rodríguez J; Vidal-Capón A; Novas S; Rodríguez-Castro J; Pequeño-Valtierra A; Pasantes JJ; Tubío JMC; Garcia-Souto D
Mol Genet Genomics; 2024 May; 299(1):58. PubMed ID: 38789628
[TBL] [Abstract][Full Text] [Related]
8. Deciphering the Epigenetic Symphony of Cancer: Insights and Epigenetic Therapies Implications.
Akram F; Tanveer R; Andleeb S; Shah FI; Ahmad T; Shehzadi S; Akhtar AM; Syed G
Technol Cancer Res Treat; 2024; 23():15330338241250317. PubMed ID: 38780251
[TBL] [Abstract][Full Text] [Related]
9. Evaluating the utility of
Nakasone ES; Zemla TJ; Yu M; Lin SY; Ou FS; Carter K; Innocenti F; Saltz L; Grady WM; Cohen SA
Epigenetics; 2024 Dec; 19(1):2349980. PubMed ID: 38716804
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide screening and functional validation of methylation barriers near promoters.
Shu J; Jelinek J; Chen H; Zhang Y; Qin T; Li M; Liu L; Issa JJ
Nucleic Acids Res; 2024 May; 52(9):4857-4871. PubMed ID: 38647050
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological characteristics of Lynch-like syndrome.
Nakamori S; Takao M; Takao A; Natsume S; Iijima T; Kojika E; Nakano D; Kawai K; Inokuchi T; Fujimoto A; Urushibara M; Horiguchi SI; Ishida H; Yamaguchi T
Int J Clin Oncol; 2024 Apr; ():. PubMed ID: 38642190
[TBL] [Abstract][Full Text] [Related]
12. MutLα suppresses error-prone DNA mismatch repair and preferentially protects noncoding DNA from mutations.
Kadyrova LY; Mieczkowski PA; Kadyrov FA
bioRxiv; 2024 Apr; ():. PubMed ID: 38617288
[TBL] [Abstract][Full Text] [Related]
13. Incidence and molecular characteristics of deficient mismatch repair conditions across nine different tumors and identification of germline variants involved in Lynch-like syndrome.
Ito T; Yamaguchi T; Kumamoto K; Suzuki O; Chika N; Kawakami S; Nagai T; Igawa T; Fujiyoshi K; Akagi Y; Arai T; Akagi K; Eguchi H; Okazaki Y; Ishida H
Int J Clin Oncol; 2024 Apr; ():. PubMed ID: 38615286
[TBL] [Abstract][Full Text] [Related]
14. Microsatellite instability: A 2024 update.
Yamamoto H; Watanabe Y; Arai H; Umemoto K; Tateishi K; Sunakawa Y
Cancer Sci; 2024 Jun; 115(6):1738-1748. PubMed ID: 38528657
[TBL] [Abstract][Full Text] [Related]
15. Small nucleolar RNA and its potential role in the oncogenesis and development of colorectal cancer.
Lan YZ; Wu Z; Chen WJ; Fang ZX; Yu XN; Wu HT; Liu J
World J Gastroenterol; 2024 Jan; 30(2):115-127. PubMed ID: 38312115
[TBL] [Abstract][Full Text] [Related]
16. The role of aberrant DNA methylation in cancer initiation and clinical impacts.
Geissler F; Nesic K; Kondrashova O; Dobrovic A; Swisher EM; Scott CL; J Wakefield M
Ther Adv Med Oncol; 2024; 16():17588359231220511. PubMed ID: 38293277
[TBL] [Abstract][Full Text] [Related]
17. Sustained Disease Control in Immune Checkpoint Blockade Responders with Microsatellite Instability-high Colorectal Cancer after Treatment Termination.
Simmons K; Thomas JV; Ludford K; Willis JA; Higbie VS; Raghav KPS; Johnson B; Dasari A; Kee BK; Parseghian CM; Lee MS; Le PH; Morelli MP; Shen JP; Bent A; Vilar E; Wolff RA; Kopetz S; Overman MJ; Morris VK
Cancer Res Commun; 2023 Dec; 3(12):2510-2517. PubMed ID: 38085001
[TBL] [Abstract][Full Text] [Related]
18. Exploring the DNA methylome of Korean patients with colorectal cancer consolidates the clinical implications of cancer-associated methylation markers.
Lee S; Lee KY; Park JH; Kim DW; Oh HK; Oh ST; Jeon J; Lee D; Joe S; Chu HBK; Kang J; Lee JY; Cho S; Shim H; Kim SC; Lee HS; Kim YJ; Yang JO; Lee J; Kang SB
BMB Rep; 2024 Mar; 57(3):161-166. PubMed ID: 37964634
[TBL] [Abstract][Full Text] [Related]
19. Unraveling Resistance to Immunotherapy in MSI-High Colorectal Cancer.
Heregger R; Huemer F; Steiner M; Gonzalez-Martinez A; Greil R; Weiss L
Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894457
[TBL] [Abstract][Full Text] [Related]
20. Mismatch Repair Deficiency Is a Prognostic Factor Predicting Good Survival of
Khuntikeo N; Padthaisong S; Loilome W; Klanrit P; Ratchatapusit S; Techasen A; Jareanrat A; Thanasukarn V; Srisuk T; Luvira V; Chindaprasirt J; Sa-Ngiamwibool P; Aphivatanasiri C; Intarawichian P; Koonmee S; Prajumwongs P; Titapun A
Cancers (Basel); 2023 Oct; 15(19):. PubMed ID: 37835526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
